ARMATA PHARMACEUTICALS INC's ticker is ARMP and the CUSIP is 04216R102. A total of 20 filers reported holding ARMATA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,747 | +674600.0% | 2,249 | +224800.0% | 0.00% | – |
| Q2 2023 | $1 | -100.0% | 1 | -100.0% | 0.00% | – |
| Q1 2023 | $6,684 | -22.1% | 4,002 | -42.2% | 0.00% | – |
| Q4 2022 | $8,578 | +7.2% | 6,918 | +269.0% | 0.00% | – |
| Q3 2022 | $8,000 | -33.3% | 1,875 | -40.1% | 0.00% | – |
| Q2 2022 | $12,000 | -7.7% | 3,131 | +14.2% | 0.00% | – |
| Q1 2022 | $13,000 | +18.2% | 2,741 | +34.6% | 0.00% | – |
| Q4 2021 | $11,000 | 0.0% | 2,036 | -29.8% | 0.00% | – |
| Q3 2021 | $11,000 | +83.3% | 2,902 | +98.0% | 0.00% | – |
| Q2 2021 | $6,000 | -79.3% | 1,466 | -75.6% | 0.00% | – |
| Q1 2021 | $29,000 | +190.0% | 6,017 | +73.4% | 0.00% | – |
| Q4 2020 | $10,000 | – | 3,471 | +347000.0% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 1 | -99.9% | 0.00% | – |
| Q2 2020 | $7,000 | 0.0% | 1,672 | -26.6% | 0.00% | – |
| Q1 2020 | $7,000 | +133.3% | 2,278 | +192.1% | 0.00% | – |
| Q4 2019 | $3,000 | +50.0% | 780 | +36.4% | 0.00% | – |
| Q3 2019 | $2,000 | -83.3% | 572 | -80.2% | 0.00% | – |
| Q2 2019 | $12,000 | – | 2,894 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 113,682 | $480,000 | 0.01% |
| SeaCrest Wealth Management, LLC | 17,550 | $74,000 | 0.01% |
| SYNOVUS FINANCIAL CORP | 47,903 | $202,000 | 0.00% |
| Edgewood Management | 100,000 | $422,000 | 0.00% |
| ROYAL BANK OF CANADA | 134 | $1,000 | 0.00% |
| VANGUARD GROUP INC | 287,350 | $1,213,000 | 0.00% |
| UBS Group AG | 1,875 | $8,000 | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 571 | $2,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 5,500 | $23,000 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 13,072 | $56,000 | 0.00% |